FORMULATION AND EVALUATION OF ZOLMITRIPTAN FAST-DISSOLVING ORAL THIN FILMS

Read full text Summarise with VIRAT
Authors: Ramya Teja Medarametla1*, Dr. J. N. Suresh Kumar2, A. Raja kumar3, A. Bindhu Sri3, A. Shaik Kousar3 R. Sravanthi3, D. Saida3
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Fast-dissolving oral thin films (OTFs) of Zolmitriptan were developed using pullulan, sodium alginate, and guar gum by the solvent casting method to enhance dissolution and bioavailability for migraine therapy. Nine formulations (F1–F9) were prepared and evaluated for physicochemical and mechanical properties. Films showed uniform thickness (0.112–0.135 mm), weight (65.6–107.4 mg), drug content (98.6–99.5%), and surface pH (6.74–6.97). Disintegration occurred within 70 s. In vitro dissolution studies demonstrated more than 90% drug release within 10 min in acidic medium. Mechanical testing confirmed adequate tensile strength and folding endurance. Pharmacokinetic studies in rabbits indicated improved bioavailability compared with oral solution. The results suggest that Zolmitriptan OTFs provide rapid drug release, enhanced bioavailability, and improved patient compliance for migraine management.

Fields of Study & Subjects

Advanced Drug Delivery Systems Drug Solubulity and Delivery Systems Inhalation and Respiratory Drug Delivery

Publication details

Journal / source
European Journal Pharmaceutical and Medical Research
Publication date
30 March 2026
Language
EN